[Studies on the antiphlogistic action of anticoagulants].
D000328:Adult; D000818:Animals; D000925:Anticoagulants / Q000627:therapeutic use*; D000991:Antithrombins / Q000032:analysis; D001777:Blood Coagulation / Q000187:drug effects; D001780:Blood Coagulation Tests; D003238:Connective Tissue / Q000378:metabolism; D003374:Coumarins / Q000627:therapeutic use; D004487:Edema / Q000188:drug therapy; D004890:Erythema / Q000188:drug therapy; D005260:Female; D006025:Glycosaminoglycans; D006099:Granuloma / Q000188:drug therapy; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D007249:Inflammation / Q000188:drug therapy*; D007616:Kaolin / Q000627:therapeutic use; D008070:Lipopolysaccharides / Q000032:analysis; D010630:Phenindione / Q000627:therapeutic use; D051381:Rats; D011919:Rats, Inbred Strains; D013431:Sulfates / Q000378:metabolism; D013460:Sulfur Isotopes; D013925:Thromboplastin / Q000032:analysis; D013997:Time Factors
D000925:Anticoagulants; D000991:Antithrombins; D003374:Coumarins; D006025:Glycosaminoglycans; D008070:Lipopolysaccharides; D013431:Sulfates; D013460:Sulfur Isotopes; D007616:Kaolin; D010630:Phenindione; D006493:Heparin; D013925:Thromboplastin
Untersuchungen zur antiphlogistischen Wirkung von Antikogulantien.